Dr. Daniel Zachary Shuster, DO

Dr. Shuster practices at Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health.

Dr. Shuster's NPI, 1326573361, was assigned on April 27, 2017. Dr. Shuster holds Michigan license 5101026253.

Dr. Shuster's primary practice is Corewell Health William Beaumont University Hospital, at 3601 W Thirteen Mile Rd, Royal Oak, MI 48073 in Oakland County. The practice phone is (248) 898-5400.

Dr. Shuster's primary practice is Corewell Health William Beaumont University Hospital in Royal Oak, Michigan, part of Corewell Health. Dr. Shuster is also affiliated with Corewell Health Beaumont Troy Hospital. The medical group on file is Beaumont Medical Group - Specialty Services. Dmand AI also links Dr. Shuster to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shuster practices, 3 sites in all. Vendor and product names are available with a free account.

Vascular neurology is Dr. Shuster's primary specialty in the NPI Registry, under taxonomy code 2084V0102X. Dr. Shuster is licensed in Michigan.

CMS data shows 509 Medicare services from Dr. Shuster across 9 procedure codes in 2024, for 185 Medicare patients. Medicare paid $50,912 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 185 Medicare patients who saw Dr. Shuster in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 19% are also on Medicaid. Their average risk score is 2.29, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shuster's median patient age at 68, with 54% women.

In 2024, Dr. Shuster wrote 443 Medicare Part D claims for 104 patients. 93% of them were for generic drugs. CMS names the drug for 275 of them, across 10 drugs with 11 or more claims each, at $21,474 in total drug cost. In 2023, CMS named 99 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Shuster for performance year 2024, reported as part of a group. Dr. Shuster accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Shuster in 2013.

CMS Open Payments shows 19 general payments to Dr. Shuster from 13 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 92% of the total. Amgen Inc. paid the most, $54.